← Back to Search

Telepsychiatry for Mental Illness (CATeleST Trial)

N/A

Waitlist Available

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

depression, schizophrenia, bipolar disorder, PTSD, dementia behavioral problems, management of psychiatric medications, and others mental health problems. Chronic medical disorders are not excluded. Study PI or co-PI will be available by phone to help with screening.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline measure at 1-, 2-, 3-, 6- and 12-months

Awards & highlights

CATeleST Trial Summary

This trial is investigating whether a new method of psychiatric consultation called Asynchronous Telepsychiatry (ATP) is as effective as the current standard, Synchronous Telepsychiatry (STP).

Eligible Conditions

Mental Illness

CATeleST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CATeleST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline measure at 1-, 2-, 3-, 6- and 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline measure at 1-, 2-, 3-, 6- and 12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline measure at 1-, 2-, 3-, 6- and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical Global Impression (CGI)- severity scale

Secondary outcome measures

Patient Satisfaction Rating

CATeleST Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Asynchronous Telepsychiatry (ATP) groupExperimental Treatment1 Intervention

Group II: Synchronous Telepsychiatry (STP) groupActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Telepsychiatry

2017

N/A

~360

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor

911 Previous Clinical Trials

4,709,348 Total Patients Enrolled

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,822,113 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for participants in this research endeavor?

"Affirmative. According to the records on clinicaltrials.gov, this investigation is actively looking for participants and began seeking enrolment in June of 2017; its most recent update was made on January 26th 2022. This study needs 250 individuals from 1 medical facility to take part."

Answered by AI

What is the current enrollment of this research study?

"Affirmative. According to clinicaltrials.gov, the recruitment phase of this trial is still underway; it was initially published on June 27th 2017 and most recently revised on January 26th 2022. The study requires 250 participants from a single site location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities

2017. "Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03264560.